Insights from our team

San Francisco Business Times. Lisa V. Sellers, PhD, CEO of Vector Laboratories, shares her insights and lessons learned for company relocation. Read article

Silicon Valley Business Journal. Lisa Sellers, PhD, CEO of Vector Laboratories, was nominated and selected to be in the 2022 Class of Women of Influence. Read her interview.  Read article

Biocompare. Erika Leonard, Director of Quality Control and R&D, Vector Laboratories, provides insights into common IHC issues and ways of resolving them.  Read article

Authority Magazine. An Interview With Charlie Katz. Lisa V Sellers of Vector Laboratories on the five things you need to succeed as a senior executive. Read article

Genetic Engineering & Biotechnology News. The new funding, backed by private equity firm Thompson Street Capital Partners, enables Vector Laboratories to embark upon an acquisition strategy while accelerating the commercialization of innovative labeling and detection technologies for immunohistochemistry, immunofluorescence, glycobiology, and bioconjugation. Read article

Endpoint News. Vector announced a $124 million cash buyout backed by private equity firm Thompson Street Capital Partners on Tuesday to fund its expansion in protein detection.  Read article